The North Carolina-based study will continue to test enrolled newborns for hundreds of childhood-onset rare genetic conditions.

Enables users to replace multiple techniques with a single streamlined NGS process for faster results.

Beckman Coulter Life Sciences has entered a collaborative partnership with Watchmaker Genomics. The partnership harnesses the value of each organization to deliver robust and reliable automated liquid handling solutions.

Stable lentiviral (LV) cell line development service achieves unconcentrated titers >1E9 TU/mL for therapeutic transgenes. Fully stable cell lines have all viral genes and transgene stably integrated.

Oxford Nanopore Technologies announced the launch of its Compatible Products Programme, a new initiative designed to establish and showcase approved compatible third-party products.

RTI International has announced that Early Check, a groundbreaking research study that provides free voluntary health tests for newborns up to four weeks old in North Carolina, has chosen Revvity, Inc. to conduct genome sequencing for the study starting in May.

Toxys announces the peer-reviewed publication of the positive results from an international interlaboratory validation of ToxTracker©. ToxTracker is an in vitro method that accurately predicts genotoxicity without the use of animals.

Collaboration aims to provide researchers cutting-edge tools to enable transformational monitoring of key biomarkers in solid tissue transplants.

Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics.

With the announcement of a $500,000 donation to the UCSC Genomics Institute in support of the UCSC Paleogenomics Lab, Colossal continues to expand its ancient DNA academic collaborations.